D. E. Shaw & Co. Inc. Acquires New Holdings in Capricor Therapeutics Inc (NASDAQ:CAPR)
D. E. Shaw & Co. Inc. acquired a new stake in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 53,734 shares of the biotechnology company’s stock, valued at approximately […]
D. E. Shaw & Co. Inc. acquired a new stake in shares of Capricor Therapeutics Inc (NASDAQ:CAPR – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 53,734 shares of the biotechnology company’s stock, valued at approximately […]
